Advances in the diagnosis of heparin-induced thrombocytopenia

Web:	mayocliniclabs.com
Email:	mcl@mayo.edu
Telephone:	800-533-1710
International:	+1 855-379-3115
Values are valid only on day of printing

Advances in the diagnosis of heparin-induced thrombocytopenia

Virtual Lecture

Expires: Mar 18, 2023

In this month’s “Virtual Lecture,” Anand Padmanabhan, M.B.B.S., Ph.D., provides an overview of diagnostic testing for heparin-induced thrombocytopenia (HIT) with an emphasis on recent advances in functional HIT testing.

Presentation

Video length: 32 minutes

Presenter

Anand Padmanabhan, M.B.B.S., Ph.D.

Consultant, Divisions of Hematopathology and Transfusion Medicine
Mayo Clinic, Rochester, MN

Learning objectives

Upon completion of this activity, participants should be able to:

Recognize the difference between antigen and functional assays for HIT diagnosis.
Explain the role of PF4-treated platelets in HIT diagnosis.
Discuss the importance of timely diagnosis for appropriate HIT management.

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.

Credit

The following types of credit are offered for this event:
ASCLS P.A.C.E.^®

Level of instruction for this program is intermediate.

To obtain credit:

Watch the video.
Complete the post-test and evaluation that launches immediately following the video.
Generate and print your certificate(s).

ASCLS P.A.C.E.^®

Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.^® program. This program has been approved for a maximum of 0.5 P.A.C.E.^® contact hour.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

Learn more about our testing

Questions?

MCL Education

This post was developed by our Education and Technical Publications Team.